Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2018-04-12 Report Publication Anno…
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Notice of AGM
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3363 characters) released via RNS (RNS Number : 6465K) on April 12, 2018. The title explicitly states it concerns the 'Posting of Annual Report and Accounts & Notice of Annual General Meeting'. According to Rule 2 (The 'MENU VS MEAL' Rule), when a document is short and announces that a report (like the Annual Report) 'has been published' and is available on the website, it should be classified as a Report Publication Announcement (RPA), not the full report itself (10-K or AR). Furthermore, it explicitly mentions the 'Notice of Annual General Meeting' (AGM), which suggests AGM-R materials are related, but since this document is merely *announcing* the posting of both the Annual Report and the AGM Notice, RPA is the most accurate classification for this specific announcement type.
2018-04-12 English
Final Results
Annual Report Classification · 1% confidence The document is titled 'FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2017' and contains comprehensive financial statements, a Chairman's statement, a Chief Executive's report, and detailed operational/financial highlights for the full fiscal year. It is not merely an announcement of a report (RPA) but the report itself, containing substantive financial data and analysis. Therefore, it is classified as an Annual Report (10-K). FY 2017
2018-04-10 English
US Patent Grant for Therapeutic Compound, VAL201
Legal Proceedings Report Classification · 1% confidence The document begins with an 'RNS Number' and is dated March 20, 2018. It announces a specific corporate event: the grant of a US Patent for a therapeutic compound (VAL201). The text explicitly states, 'ValiRx Plc... is pleased to announce that the United States of America patent and trademark office has granted the US Patent Application...'. This is a specific corporate update regarding intellectual property and clinical progress, not a full financial report (10-K, IR) or a general earnings release (ER). Since it is a specific, material announcement disseminated via the RNS system, and it doesn't fit perfectly into categories like DIRS, DIV, or CAP, the most appropriate classification is the general regulatory announcement category, RNS, as it is a direct regulatory news service release detailing a significant, non-financial event. However, upon reviewing the definitions, the content is a specific announcement about a patent grant, which is a form of corporate development/IP news. While RNS is a fallback, the content is highly specific. It is not a Director's Dealing (DIRS), a Capital change (CAP), or a Legal Proceeding (LTR). Given the nature of the announcement (patent grant, clinical trial update context), it is a material regulatory disclosure. Since there is no specific 'Intellectual Property Update' category, RNS serves as the best fit for a general, material regulatory news service announcement.
2018-03-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 0535I' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification as MRQ, as MRQ is a more specific category than the general RNS fallback.
2018-03-19 English
Appointment of Broker
Board/Management Information Classification · 1% confidence The document is very short (2974 characters) and is identified by an 'RNS Number' (0354I), indicating it is a regulatory announcement from the London Stock Exchange's news service. The content announces the 'Appointment of Broker' (Novum Securities Limited) and explicitly states that the announcement contains 'inside information for the purposes of Article 7 of EU Regulation 596/2014'. This type of specific, brief corporate action announcement that is disseminated via the RNS system typically falls under the general 'Regulatory Filings' category, as there is no specific code for 'Broker Appointment'. It is not a full report (10-K, IR), an earnings release (ER), or a management change (MANG), although it relates to corporate structure. Given the nature of the RNS dissemination and the content being a specific corporate action update, RNS is the most appropriate classification, serving as the general regulatory announcement fallback.
2018-03-16 English
Statement re broker
Legal Proceedings Report Classification · 1% confidence The document is identified by the 'RNS Number' header and the closing statement indicating the information is provided by 'RNS The company news service from the London Stock Exchange'. The content is a brief announcement regarding the insolvency of the company's broker (Beaufort Securities Limited) and the subsequent need to appoint a new broker. This type of immediate, material corporate update that does not fit into specific categories like earnings, dividends, or director dealings is best classified as a general regulatory announcement. Since it is a direct regulatory filing notification, the most appropriate code is RNS (Regulatory Filings), which serves as the general category for such announcements.
2018-03-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.